Functional analysis of backbone cyclic peptides bearing the arm domain of the HIV-1 Rev protein: Characterization of the karyophilic properties and inhibition of Rev-induced gene expression

Biochemistry

Volumn 44, Issue 34, 2005, Pages 11555-11566

  Hariton Gazal, Elana ^a   Rosenbluh, Joseph ^a   Zakai, Nechama ^a   Fridkin, Gil ^a   Brack Werner, Ruth ^b   Wolff, Horst ^b   Devaux, Christian ^c   Gilon, Chaim ^a   Loyter, Abraham ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

^c CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BIODIVERSITY; BLOOD; CELLS; GENES; PROTEINS; SYNTHESIS (CHEMICAL); VIRUSES;

BINDING PROPERTIES; FUNCTIONAL ANALYSIS; MICROMOLAR RANGE; PEPTIDES;

AMINO ACIDS;

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; ARGININE; BIS(TRICHLOROMETHYL)CARBONATE; BOVINE SERUM ALBUMIN; CARBONIC ACID; CHLORINE DERIVATIVE; CYCLOPEPTIDE; GREEN FLUORESCENT PROTEIN; KARYOPHERIN BETA; METHYL GROUP; PEPTIDE LIBRARY; REV PROTEIN; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ARTICLE; CELL MEMBRANE PERMEABILITY; CONJUGATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; GENE INDUCTION; HELA CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IN VITRO STUDY; NONHUMAN; NUCLEAR LOCALIZATION SIGNAL; PEPTIDE ANALYSIS; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN DOMAIN; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION; QUANTITATIVE ANALYSIS;

AMINO ACID SEQUENCE; ARGININE; BINDING SITES; GENE EXPRESSION REGULATION, VIRAL; GENE PRODUCTS, REV; GUANOSINE TRIPHOSPHATE; HELA CELLS; HIV-1; HUMANS; PEPTIDE LIBRARY; PEPTIDES, CYCLIC; PROTEIN CONFORMATION; RECOMBINANT PROTEINS;

BOVINAE; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 23944478347     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi050752b     Document Type: Article

References (71)

1. Marsh, M., and Helenius, A. (1989) Virus entry into animal cells, Adv. Virus Res. 36, 107-51.
2. Whittaker, G. R., Kann, M., and Helenius, A. (2000) Viral entry into the nucleus, Annu. Rev. Cell Dev. Biol. 16, 627-51.
3. Sherman, M. P., and Greene, W. C. (2002) Slipping through the door: HIV entry into the nucleus, Microbes Infect. 4, 67-73.
4. Kiso, Y. (1996) Design and synthesis of substrate-based peptidomimetic human immunodeficiency virus protease inhibitors containing the hydroxymethylcarbonyl isostere, Biopolymers 40, 235-44.
5. Reid, R. C., and Fairlie, D. P. (1997) Mimicking extended conformations of protease substrates: Designing cyclic peptidomimetics to inhibit HIV-1 protease, Adv. Amino Acid Mimetics Peptidomimetics 1, 77-107.
6. Kieber-Emmons, T., Murali, R., and Greene, M. I. (1997) Therapeutic peptides and peptidomimetics, Curr. Opin. Biotechnol. 8, 435-41.
7. Gilon, C., Lohof, E., Friedler, A., and Kessler, H. (2003) Synthesis of Cyclic Peptides, in Houben-Weyl: Methods of Organic Chemistry (Goodman, M., Felix, A., Moroder, L., and Toniolo, C., Eds.) Vol. E 22b, Synthesis of Peptides and Peptidomimetics, pp 461-542, Thieme Verlag, Stuttgart, Germany.
8. Friedler, A., Zakai, N., Kami, O., Broder, Y. C., Baraz, L., Kotler, M., Loyter, A., and Gilon, C. (1998) Backbone cyclic peptide, which mimics the nuclear localization signal of human immunodeficiency virus type 1 matrix protein, inhibits nuclear import and virus production in nondividing cells, Biochemistry 37, 5616-22.
9. Friedler, A., Friedler, D., Luedtke, N., Tor, Y., Loyter, A., and Gilon, C. (2000) Development of a functional backbone cyclyc mimetics of the HIV-1 Tat arginine-rich motif, J. Biol. Chem. 275, 23783-9.
10. Schmidtmayerova, H., Nuovo, G. J., and Bukrinsky, M. (1997) Proliferation is not required for productive HIV-1 infection of macrophages, Virology 232, 379-84.
11. Bukrinsky, M. I., Haggerty, S., Dempsey, M. P., Sharova, N., Adzhubel, A., Spitz, L., Lewis, P., Goldfarb, D., Emerman, M., and Stevenson, M. (1993) A nuclear localization signal within HIV-1 matrix protein that governs infection of non-dividing cells, Nature 365, 666-9.
12. Haffar, O. K., Popov, S., Dubrovsky, L., Agostini, I., Tang, H., Pushkarsky, T., Nadler, S. G., and Bukrinsky, M. (2000) Two nuclear localization signals in the HIV-1 matrix protein regulate nuclear import of the HIV-1 pre-integration complex, J. Mol. Biol. 299, 359-68.
13. Bukrinsky, M., and Haffar, O. (1999) HIV-1 nuclear import: In search of a leader, Front. Biosci. 4, 772-81.
14. Fouchier, R. A. M., Meyer, B. E., Simon, J. H. M., Fischer, U., and Malim, M. H. (1997) HIV-1 infection of non-dividing cells: Evidence that the amino-terminal basic region of the viral matrix protein is important for Gag processing but not for post-entry nuclear import, EMBO J. 16, 4531-9.
15. Bouyac-Bertoia, M., Dvorin, J. D., Fouchier, R. A. M., Jenkins, Y., Meyer, B. E., Wu, L. I., Emerman, M., and Malim, M. H. (2001) HIV-1 Infection Requires a Functional Integrase NLS, Mol. Cell 7, 1025-35.
16. Kingsman, S. M., and Kingsman, A. J. (1996) The regulation of human immunodeficiency virus type-1 gene expression, Eur. J. Biochem. 240, 491-507.
17. Emerman, M., and Malim, M. H. (1998) HIV-1 regulatory/ accessory genes: Keys to unraveling viral and host cell biology, Science 280, 1880-4.
18. Freed, E. O. (2001) HIV-1 replication, Somatic Cell Mol. Genet. 26, 13-33.
19. Truant, R., and Cullen, B. R. (1999) The arginine-rich domains present in HIV-1 Tat and Rev function as direct importin β dependent nuclear localization signals, Mol. Cell. Biol. 19, 1210-7.
20. Abdoul-ela, F., Karn, J., and Varani, G. (1995) The structure of the HIV-1 TAR RNA reveals principles of RNA recognition by Tat protein, J. Mol. Biol. 253, 313-32.
21. Karn, J. (1999) Tackling Tat, J. Mol. Biol. 293, 235-54.
22. Malim, M. H., Hauber, J., Le, S. Y., Maizel, J. V., and Cullen, B. R. (1989) The HIV-1 rev trans-activator acts through a structured target sequence to activate nuclear export of unspliced viral mRNA, Nature 338, 254-7.
23. Battiste, J. L., Mao, H., Rao, N. S., Tan, R., Muhandiram, D. R., Kay, L. E., Frankel, L. E., and Williamson, J. R. (1996) α-Helix-RNA major groove recognition in an HIV-1 Rev peptide-RRE RNA complex, Science 273, 1547-51.
24. Wilkinson, T. A., Botuyan, M. V., Kaplan, B. E., Rossi, J. J., and Chen, Y. (2000) Arginine Side-chain Dynamics in the HIV-1 Rev-RRE Complex, J. Mol. Biol. 303, 515-29.
25. Fischer, U., Meyer, S., Teufel, M., Heckel, C., Luhrmann, R., and Rautmann, G. (1994) Evidence that HIV-1 Rev directly promotes the nuclear export of unspliced RNA, EMBO J. 13, 4105-12.
26. Thomas, C. A., Dobkin, J., and Weinberger, O. K. (1994) TAT-mediated transcellular activation of HIV-1 long terminal repeat directed gene expression by HIV-1-infected peripheral blood mononuclear cells, J. Immunol. 153, 3831-9.
27. Ziegler, A., Nervi, P., Durrenberger, M., and Seelig, J. (2005) The cationic cell-penetrating peptide CPP(TAT) derived from the HIV-1 protein TAT is rapidly transported into living fibroblasts: Optical, biophysical, and metabolic evidence, Biochemistry 44, 138-48.
28. Rusnati, M., and Presta, M. (2002) HIV-1 Tat protein and endothelium: From protein/cell interaction to AIDS-associated pathologies, Angiogenesis 5, 141-51.
29. Futaki, S., Suzuki, T., Ohashi, W., Yagami, T., Tanaka, S., Ueda, K., and Sugiura, Y. (2000) Arginine rich peptides: An abundant source of membrane permeable peptides having potential as carriers for intercellular protein delievery, J. Biol. Chem. 276, 5836-40.
30. Joliot, A., and Prochiantz, A. (2005) Transduction peptides, the useful face of a new signaling mechanism, Med. Sci. (Paris) 21, 309-14.
31. Vives, E., Brodin, P., and Lebleu, B. (1997) A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus, J. Biol. Chem. 272, 16010-7.
32. Nakaya, T., Iwai, S., Fujinaga, K., Sato, Y., Otsuka, E., and Ikuta, K. (1997) Decoy approach using RNA-DNA chimera oligonucleotides to inhibit the regulatory function of human immunodeficiency virus type 1 Rev protein, Antimicrob. Agents Chemother. 41, 319-25.
33. Lisziewicz, J., Zeng, G., Gratas, C., Weinstein, J. N., and Lori, F. (2000) Combination gene therapy: Synergistic inhibition of human immunodeficiency virus Tat and Rev functions by a single RNA molecule, Hum. Gene Ther. 11, 807-15.
34. Suzuki, T., Futaki, S., Niwa, M., Tanaka, S., Ueda, K., and Sugiura, Y. (2002) Possible existence of common internalization mechanisms among arginine-rich peptides, J. Biol. Chem. 277, 2437-43.
35. Zorko, M., and Langel, U. (2005) Cell-penetrating peptides: Mechanism and kinetics of cargo delivery, Adv. Drug Delivery Rev. 57, 529-45.
36. Brooks, H., Lebleu, B., and Vives, E. (2005) Tat peptide-mediated cellular delivery: Back to basics, Adv. Drug Delivery Rev. 57, 559-77.
37. Snyder, E. L., and Dowdy, S. F. (2004) Cell penetrating peptides in drug delivery, Pharm. Res. 21, 389-93.
38. Hariton-Gazal, E., Friedler, D., Friedler, A., Zakai, N., Gilon, C., and Loyter, A. (2002) Inhibition of nuclear import by backbone cyclic peptidomimetics derived from the HIV-1 MA NLS sequence, Biochim. Biophys. Acta 1594, 234-42.
39. Falb, E., Yechezkel, T., Salitra, Y., and Gilon, C. (1999) In situ generation of Fmoc-amino acid chlorides using bis-(trichloromethyl) carbonate and its utilization for difficult couplings in solid-phase peptide synthesis, J. Pept. Res. 53, 507-17.
40. Broder, Y. C., Stanhill, A., Zakai, N., Friedler, A., Gilon, C., and Loyter, A. (1997) Translocation of NLS-BSA conjugates into nuclei of permeabilized mammalian cells can be supported by protoplast extract: An experimental system for studying plant cytosolic factors involved in nuclear import, FEBS Lett. 412, 535-9.
41. Fineberg, K., Fineberg, T., Graessmann, A., Luedtke, N. W., Tor, Y., Lixin, R., Jans, D. A., and Loyter, A. (2003) Inhibition of nuclear import mediated by the Rev-arginine rich motif by RNA molecules, Biochemistry 42, 2625-33.
42. Krichevsky, A. M. R., Bugatti, A., Shohat, S., and Loyter, A. (2005) The fd phage and a peptide derived from its p8 coat protein interact with the HIV-1 Tat NLS and inhibit its biological functions, Antiviral Res. 66, 67-78.
43. Melchior, F., Paschal, B., Evans, J., and Gerace, L. (1993) Inhibition of nuclear import by the non-hydrolyzable analogues of GTP and identification of the small GTPase Ran/TC4 as an essential transport factor, J. Cell Biol. 123, 1649-59.
44. Hariton-Gazal, E., Rosenbluh, J., Graessmann, A., Gilon, C., and Loyter, A. (2003) Direct translocation of histone molecules across cell membranes, J. Cell Sci. 116, 4577-86.
45. Chico, D. E., Given, R. L., and Miller, B. T. (2003) Binding of cationic cell-permeable peptides to plastic and glass, Peptides 24, 3-9.
46. Wolff, H., Brack-Werner, R., Neumann, M., Werner, T., and Schneider, R. (2003) Integrated functional and bioinformatics approach for the identification and experimental verification of RNA signals: Application to HIV-1 INS, Nucleic Acids Res. 31, 2839-51.
47. Kramer-Hammerle, S.. Ceccherini-Silberstein, F., Bickel, C., Wolff, H., Vincendeau, M., Werner, T., Erfle, V., and Brack-Werner, R. (2005) Identification of a novel Rev-interacting cellular protein, BMC Cell Biol. (in press).
48. Schwartz, S., Felber, B. K., Benko, D. M., Fenyo, E. M., and Pavlakis, G. N. (1990) Cloning and functional analysis of multiply spliced mRNA species of human immunodeficiency virus type 1, J. Virol. 64, 2519-29.
49. Ludwig, E., Silberstein, F., Van Empel, J., Erfle, V., Neumann, M., and Brack-Werner, R. (1999) Diminished rev-mediated stimulation of human immunodeficiency virus type 1 protein synthesis is a hallmark of human astrocytes, J. Virol. 73, 8279-89.
50. Battiste, J. L., Mao, H., Rao, N. S., Tan, R., Muhandiram, D. R., Kay, L. E., Frankel, A. D., and Williamson, J. R. (1996) α-Helix-RNA major groove recognition in an HIV-1 Rev peptide-RRE RNA complex, Science 273, 1547-51.
51. Tan, R., Chen, L., Buettner, J. A., Hudson, D., and Frankel, A. D. (1993) RNA recognition by an isolated α helix, Cell 73, 1031-40.
52. Kami, O., Friedler, A., Zakai, N., Gilon, C., and Loyter, A. (1998) A peptide derived from the N-terminal region of HIV-1 Vpr promotes nuclear import in permeabilized cells: elucidation of the NLS region of the Vpr, FEBS Lett. 429, 421-5.
53. Rosenbluh, J., Hariton-Gazal, E., Dagan, A., Rottem, S., Graessmann, A., and Loyter, A. (2005) Translocation of histone proteins across lipid bilayers and Mycoplasma membranes, J. Mol. Biol. 345, 387-400.
54. Skrzypek, E., Cowan, C., and Straley, S. (1998) Targeting of the Yersinia pestis YopM protein into HeLa cells and intracellular trafficking to the nucleus, Mol. Microbiol. 30, 1051-65.
55. Stuart, A. D., Eustace, H. E., McKee, T. A., and Brown, T. D. (2002) A novel cell entry pathway for a DAF-using human enterovirus is dependent on lipid rafts, J. Virol. 76, 9307-22.
56. Elliott, G., and O'Hare, P. (1997) Intercellular trafficking and protein delivery by a herpesvirus structural protein, Cell 88, 223-33.
57. Bayer, N. D., Schober, D., Prchla, E., Murphy, R. F., Blaas, D., and Fuchs, R. (1998) Effect of Bafilomycin A1 and Nocodazole on Endocytic Transport in HeLa Cells: Implications for Viral Uncoating and Infection, J. Virol. 72, 9645-55.
58. Vives, E. (2003) Cellular uptake of the Tat peptide: An endocytosis mechanism following ionic interactions, J. Mol. Recognit. 16, 265-71.
59. Nigg, E. A. (1997) Nucleocytoplasmic transport: Signals, mechanisms and regulation, Nature 386, 779-87.
60. Mattaj, I. W., and Englmeier, L. (1998) Nucleocytoplasmic transport: The soluble phase, Annu. Rev. Biochem. 67, 265-306.
61. Adam, E. A., and Adam, S. A. (1994) Identification of cytosolic factors required for nuclear localization sequence-mediated binding to the nuclear envelope, J. Cell Biol. 125, 547-55.
62. Wu, Y., and Marsh, J. W. (2003) Gene transcription in HIV infection, Microbes Infect. 5, 1023-7.
63. Seelamgari, A., Maddukuri, A., Berro, R., de la Fuente, C., Kehn, K., Deng, L., Dadgar, S., Bottazzi, M. E., Ghedin, E., Pumfery, A., and Kashanchi, F. (2004) Role of viral regulatory and accessory proteins in HIV-1 replication, Front. Biosci. 9, 2388-413.
64. Futaki, S., Goto, S., and Sugiura, Y. (2003) Membrane permeability commonly shared among arginine-rich peptides, J. Mol. Recognit. 16, 260-4.
65. Futaki, S., Goto, S., Suzuki, T., Nakase, I., and Sugiura, Y. (2003) Structural variety of membrane permeable peptides, Curr. Protein Pept. Sci. 4, 87-96.
66. Ptak, R. G. (2002) HIV-1 regulatory proteins: Targets for novel drug development, Expert Opin. Invest. Drugs 11, 1099-115.
67. Baba, M. (2004) Inhibitors of HIV-1 gene expression and transcription, Curr. Top. Med. Chem. 4, 871-82.
68. Roisin, A., Robin, J. P., Dereuddre-Bosquet, N., Vitte, A. L., Dormont, D., Clayette, P., and Jalinot, P. (2004) Inhibition of HIV-1 replication by cell-penetrating peptides binding Rev, J. Biol. Chem. 279, 9208-14.
69. Friedler, A., Luedtke, N., Friedler, D., Loyter, A., Tor, Y., and Gilon, C. (1999) in 16th American Peptide Symposium (Fields, G. B., Ed.) Minneapolis, MN.
70. Dingwall, C. (1991) Transport across the nuclear envelope: Enigmas and explanations, BioEssays 13, 213-8.
71. Lundberg, M., and Johansson, M. (2002). Positively charged DNA binding proteins cause apparent cell membrane translocation, Biochem. Biophys. Res. Commun. 291, 367-71.